Clinical and immunogenetic features of patients with autoantibodies to asparaginyl–transfer RNA synthetase
Open Access
- 28 March 2007
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 56 (4) , 1295-1303
Abstract
Objective: We have previously described anti‐KS autoantibodies and provided evidence that they are directed against asparaginyl–transfer RNA (tRNA) synthetase (AsnRS). The aim of the present study was to identify patients with anti‐AsnRS autoantibodies and elucidate the clinical significance of this sixth antisynthetase antibody. In particular, we studied whether it was associated with the syndrome of myositis (polymyositis or dermatomyositis [DM]), interstitial lung disease (ILD), arthritis, and other features that had been previously associated with the 5 other anti–aminoacyl–tRNA synthetase autoantibodies.Methods: More than 2,500 sera from patients with connective tissue disease (including myositis and ILD) and controls were examined for anti‐AsnRS autoantibodies by immunoprecipitation (IP). Positive and control sera were tested for the ability to inhibit AsnRS by preincubation of the enzyme source with the serum. The HLA class II (DRB1, DQA1, DQB1, DPB1) alleles were identified from restriction fragment length polymorphism of polymerase chain reaction–amplified genomic DNA.Results: Anti‐AsnRS antibodies were identified in the sera of 8 patients (5 Japanese, 1 American, 1 German, and 1 Korean) by IP of the same distinctive set of tRNA and protein that differed from those precipitated by the other 5 antisynthetases, and these antibodies showed specific inhibition of AsnRS activity. Two of these patients had DM, but 7 of 8 (88%) had ILD. Four patients (50%) had arthritis, and 1 had Raynaud's phenomenon. This antisynthetase was very rare among myositis patients (present in 0% of Japanese myositis patients), but it was found in 3% of Japanese ILD patients. Thus, most patients with anti‐AsnRS had chronic ILD with or without features of connective tissue disease. Interestingly, all 4 Japanese patients tested had DR2 (DRB1*1501/1502), compared with 33% of healthy controls.Conclusion: These results indicate that anti‐AsnRS autoantibodies, like anti–alanyl–tRNA synthetase autoantibodies, have a stronger association with ILD than with myositis and may be associated with the DR2 phenotype.Keywords
This publication has 34 references indexed in Scilit:
- Association between autoantibodies to the Ku protein and DPB1*Arthritis & Rheumatism, 2005
- Frequent occurrence of anti-tRNAHis autoantibodies that recognize a conformational epitope in sera of patients with myositisArthritis & Rheumatism, 1998
- Autoantibodies to glycyl–transfer RNA synthetase in myositis. Association with dermatomyositis and immunologic heterogeneityArthritis & Rheumatism, 1996
- Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase.Journal of Clinical Investigation, 1993
- Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in japanese patients with inflammatory muscle diseaseArthritis & Rheumatism, 1992
- A New Approach to the Classification of Idiopathic Inflammatory MyopathyMedicine, 1991
- Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease.Journal of Clinical Investigation, 1989
- Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody.Journal of Experimental Medicine, 1984
- Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease.BMJ, 1984
- The Precipitating Antibody to an Acidic Nuclear Protein Antigen, the Jo‐1, in Connective Tissue DiseasesArthritis & Rheumatism, 1983